{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:59:53Z","timestamp":1790657993768,"version":"4.1.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>In this study, we assessed the prevalence and predisposing factors of non-infectious CIED lead masses as incidental finding during transoesophageal echocardiography (TOE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a retrospective single centre study, we analysed TOE examinations performed for indications other than infectious endocarditis in 141 patients with CIED. Patients with non-suspicious leads and those with incidental non-infectious lead masses were compared with respect to clinical characteristics, anticoagulation, indication for TOE, and CIED lead characteristics. The odds ratios for non-infectious CIED lead masses were calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Non-infectious CIED lead masses were detected in 39 (27.6%) of the 141 patients. They were more often identified on ICD and CRT-D leads compared to pacemaker and CRT-P leads [OR 2.77 (95% CI 1.29\u20135.95), <jats:italic>p<\/jats:italic> = 0.008]. The lifespan of the CIEDs from the first implantation to the index TOE did not differ between both groups. Incidental CIED lead masses were more prevalent in patients who received their device for primary prevention of sudden cardiac death (43.2%) and for resynchronisation (63.6%) but were less prevalent in patients with oral anticoagulation [OR.33 (95% CI.003\u20131.003), <jats:italic>p<\/jats:italic> = 0.048].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Incidental non-infectious CIED lead masses were frequently found in TOE, with highest prevalence in ICD and CRT-D devices implanted for patients with dilated cardiomyopathy. Patients with therapeutic anticoagulation had significantly lower prevalence of CIED lead masses than those without.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.879505","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T11:10:07Z","timestamp":1655205007000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and Predisposing Factors of Non-infectious Cardiac Implantable Electronic Device Lead Masses as Incidental Finding During Transoesophageal Echocardiography: A Retrospective Cohort Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Tanja","family":"Kuecken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Jasaityte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"B\u00fclow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Haase-Fielitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Neuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Butter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021.","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2014-000177","article-title":"Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population.","volume":"1","author":"Bradshaw","year":"2014","journal-title":"Open Heart."},{"key":"B3","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/europace\/eux258","article-title":"A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association.","volume":"19","author":"Raatikainen","year":"2017","journal-title":"Europace."},{"key":"B4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/europace\/euz246","article-title":"European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"22","author":"Blomstr\u00f6m-Lundqvist","year":"2020","journal-title":"Europace."},{"key":"B5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3238\/arztebl.2018.0445","article-title":"The diagnosis and treatment of pacemaker-associated infection.","volume":"115","author":"D\u00f6ring","year":"2018","journal-title":"Dtsch Arztebl Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1016\/j.hrthm.2017.09.001","article-title":"2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.","volume":"14","author":"Kusumoto","year":"2017","journal-title":"Heart Rhythm."},{"key":"B7","first-page":"599","article-title":"Incidence and prognosis of pacemaker lead-associated masses: a study of 1,569 transesophageal echocardiograms.","volume":"18","author":"Lo","year":"2006","journal-title":"J Invasive Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1540-8159.2011.03034.x","article-title":"Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography.","volume":"34","author":"Downey","year":"2011","journal-title":"Pacing Clin Electrophysiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European Society of Cardiology: cardiovascular disease statistics 2017.","volume":"39","author":"Timmis","year":"2018","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4065\/74.2.120","article-title":"Postmortem analysis of encapsulation around long-term ventricular endocardial pacing leads.","volume":"74","author":"Candinas","year":"1999","journal-title":"Mayo Clin Proc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/01.cir.39.4.495","article-title":"Autopsy findings with permanent pervenous pacemakers.","volume":"39","author":"Robboy","year":"1969","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1111\/j.1540-8159.1995.tb03868.x","article-title":"Anatomical findings in patients having had a chronically indwelling coronary sinus defibrillation lead.","volume":"18","author":"Jones","year":"1995","journal-title":"Pacing Clin Electrophysiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/jbm.10306","article-title":"Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads.","volume":"63","author":"Esposito","year":"2002","journal-title":"J Biomed Mater Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/europace\/eur384","article-title":"Differences in encapsulating lead tissue in patients who underwent transvenous lead removal.","volume":"14","author":"Ko\u0142odzi\u0144ska","year":"2012","journal-title":"Europace."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jjcc.2017.01.011","article-title":"Neointimal fibrotic lead encapsulation - Clinical challenges and demands for implantable cardiac electronic devices.","volume":"70","author":"Keiler","year":"2017","journal-title":"J Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/europace\/eur274","article-title":"Histological findings around electrodes in pacemaker and implantable cardioverter-defibrillator patients: comparison of steroid-eluting and non-steroid-eluting electrodes.","volume":"14","author":"Dvorak","year":"2011","journal-title":"Europace."},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/1054-8807(95)00023-x","article-title":"The encapsulation of polyurethane-insulated transvenous cardiac pacemaker leads.","volume":"4","author":"Stokes","year":"1995","journal-title":"Cardiovasc Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.echo.2018.10.018","article-title":"Intracardiac flow analysis: techniques and potential clinical applications.","volume":"32","author":"Mele","year":"2019","journal-title":"J Am Soc Echocardiogr."},{"key":"B19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure.","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1161\/CIRCULATIONAHA.115.018521","article-title":"Positron emission tomography\/computed tomography imaging in device infective endocarditis: ready for prime time.","volume":"132","author":"Lancellotti","year":"2015","journal-title":"Circulation."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.879505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T11:10:13Z","timestamp":1655205013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.879505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":20,"alternative-id":["10.3389\/fcvm.2022.879505"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.879505","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"article-number":"879505"}}